Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

2011 ◽  
Vol 91 (4) ◽  
pp. 543-551 ◽  
Author(s):  
Hye Jin Kang ◽  
Won Seog Kim ◽  
Seok Jin Kim ◽  
Je-Jung Lee ◽  
Deok-Hwan Yang ◽  
...  
Keyword(s):  
Phase Ii ◽  
Combination Chemotherapy ◽  
Marginal Zone ◽  
Phase Ii Trial ◽  
Marginal Zone Lymphoma ◽  
Advanced Stage ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

2002 ◽  
Vol 7 (5) ◽  
pp. 410-417 ◽  
Author(s):  
Mohammad Jahanzeb ◽  
Joanne E. Mortimer ◽  
Furhan Yunus ◽  
David H. Irwin ◽  
James Speyer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer

2006 ◽  
Vol 60 (1) ◽  
pp. 57 ◽  
Author(s):  
Hye Cheol Jeong ◽  
Sang Yeub Lee ◽  
Jung Ha Kim ◽  
Eun Sil Ha ◽  
Jin Yong Jung ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer

Head & Neck ◽  
2011 ◽  
Vol 34 (9) ◽  
pp. 1225-1230 ◽  
Author(s):  
Daniel T. T. Chua ◽  
Harry Ho-Yin Yiu ◽  
Kasan Seetalarom ◽  
Alice Wan-Ying Ng ◽  
Johan Kurnianda ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Nasopharyngeal Cancer ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document